High-Dose Aumolertinib for Untreated EGFR-Variant Non-Small Cell Lung Cancer With Brain Metastases: The ACHIEVE Phase 2 Nonrandomized Clinical Trial.
Li H, Chen K, Gong L, Qin J, Jin Y, Zhou R, Huang Z, Xu Y, Xu X, He J, Zhu J, Yu S, Lu H, Xu Y, Yu X, Han G, Chen J, Tan W, Lou G, Ren B, Chen X, Zhang D, Wang W, Shi X, Xie F, Zhao J, Han N, Li B, Fan Y.
Li H, et al. Among authors: ren b.
JAMA Oncol. 2025 Jun 26:e251779. doi: 10.1001/jamaoncol.2025.1779. Online ahead of print.
JAMA Oncol. 2025.
PMID: 40569623
Free PMC article.